THE long-promised era of personalised medicine, when doctors will tailor treatments to match a particular patient’s genes, is beginning to dawn. A gene test that could help ensure people are not under or overdosed with many drugs was launched in the European Union last week.
“As far as I’m aware, this is the first commercial diagnostic test for personalised medicine,” says Doris-Ann Williams, director of the British In Vitro Diagnostics Association. But she fears that at around €450 per test it will be an option only for wealthier patients.
The test, sold by Roche Diagnostics of Basle, Switzerland, is based…
